Brilliant Bio Pharma Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 12.71 Cr
as on 16-11-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 80.47 Cr
as on 16-11-2024
- Revenue 39.99%
(FY 2023)
- Profit 9838.35%
(FY 2023)
- Ebitda 38.18%
(FY 2023)
- Net Worth 61.60%
(FY 2023)
- Total Assets -5.92%
(FY 2023)
About Brilliant Bio Pharma
The Corporate was formerly known as Brilliant Industries Limited.. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 12.71 Cr.
The company currently has active open charges totaling ₹80.47 Cr.
The Key Managerial Personnel (KMP) at Brilliant Bio Pharma Private Limited India is Mourya Boda as CEO. Hari Reddy, Shukacharya Manur, and Srinivasa Talluri serve as directors at the Company.
- CIN/LLPIN
U24100TG2010PTC067485
- Company No.
067485
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Brilliant Bio Pharma Private Limited offer?
Brilliant Bio Pharma Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Injections, Veterinary Vaccines, Immunization & Vaccination Drugs, Rabies Vaccine, Ivermectin Injection, Antibiotic Injection, Ceftriaxone Injection, FMD Vaccine, Veterinary Bolus.
Who are the key members and board of directors at Brilliant Bio Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mourya Boda | CEO | 30-Sep-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hari Reddy  | Whole-Time Director | 10-Jun-2013 | Current |
| Shukacharya Manur | Director | 19-Aug-2020 | Current |
| Srinivasa Talluri | Additional Director | 25-Jul-2024 | Current |
Financial Performance of Brilliant Bio Pharma.
Brilliant Bio Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.99% increase. The company also saw a substantial improvement in profitability, with a 9838.35% increase in profit. The company's net worth Soared by an impressive increase of 61.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brilliant Bio Pharma?
In 2023, Brilliant Bio Pharma had a promoter holding of 83.27% and a public holding of 16.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 20 Jun 2023 | ₹1.13 Cr | Open |
State Bank Of India Creation Date: 22 Apr 2022 | ₹4.98 Cr | Open |
State Bank Of India Creation Date: 15 Jan 2021 | ₹10.13 Cr | Open |
How Many Employees Work at Brilliant Bio Pharma?
Brilliant Bio Pharma has a workforce of 163 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brilliant Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brilliant Bio Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
